INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
129 hedge funds and large institutions have $1.56B invested in Infinity Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 45 increasing their positions, 50 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
-8
Holders Change %
-5.84%
% of All Funds
3.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
45
Reduced
50
Closed
24
Calls
$6.52M
Puts
$4.03M
Net Calls
+$2.49M
Net Calls Change
+$2.01M
Top Buyers
| 1 |
ACM
Americafirst Capital Management
Roseville,
California
|
+$243M |
| 2 |
DM
Deerfield Management
New York
|
+$12.2M |
| 3 |
PA
Pinnacle Associates
New York
|
+$11.4M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$4.99M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.02M |
Top Sellers
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$7.55M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$5.89M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$4.04M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.4M |
| 5 |
Renaissance Technologies
New York
|
-$2.71M |
